Drugs Made In America Acquisition Corp. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FIRST TRUST CAPITAL MANAGEMENT L.P. | 02/13/2026 | 2.24 M | $23.26 M | 0.00% | 9.75% |
| GLAZER CAPITAL, LLC | 02/13/2026 | 1.82 M | $18.84 M | -0.32% | 7.90% |
| WESTCHESTER CAPITAL MANAGEMENT, LLC | 02/13/2026 | 1.67 M | $17.31 M | 0.00% | 7.26% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/13/2026 | 1.55 M | $16.07 M | 0.00% | 6.74% |
| MIZUHO SECURITIES USA LLC | 02/09/2026 | 1.43 M | $14.77 M | 30.26% | 6.23% |
| WOLVERINE ASSET MANAGEMENT LLC | 02/02/2026 | 1.31 M | $13.56 M | 4.67% | 5.68% |
| HEIGHTS CAPITAL MANAGEMENT, INC | 02/17/2026 | 650.00 K | $6.74 M | 0.00% | 2.83% |
| RADCLIFFE CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 546.81 K | $5.67 M | 3.54% | 2.38% |
| LMR PARTNERS LLP | 02/17/2026 | 500.00 K | $5.19 M | 0.00% | 2.17% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 02/17/2026 | 418.00 K | $4.33 M | 31.45% | 1.82% |
| CLEAR STREET GROUP INC. | 02/13/2026 | 325.97 K | $995.64 M | 55.55% | 1.42% |
| QUARRY LP | 02/13/2026 | 266.55 K | $2.77 M | 1,595.51% | 1.16% |
| CONTEXT CAPITAL MANAGEMENT, LLC | 02/13/2026 | 250.00 K | $2.59 M | 0.00% | 1.09% |
| 02/13/2026 | 200.00 K | $2.07 B | 100.00% | 0.87% | |
| TORONTO DOMINION BANK | 02/17/2026 | 200.00 K | $2.07 M | -55.56% | 0.87% |
| BULLDOG INVESTORS, LLP | 02/13/2026 | 130.26 K | $1.35 M | 0.00% | 0.57% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 119.69 K | $1.24 M | 0.00% | 0.52% |
| DLD ASSET MANAGEMENT, LP | 02/13/2026 | 100.56 K | $1.04 M | -11.54% | 0.44% |
| WARBERG ASSET MANAGEMENT LLC | 02/13/2026 | 92.06 K | $955.07 K | 0.00% | 0.40% |
| PERISCOPE CAPITAL INC. | 02/10/2026 | 50.00 K | $518.75 K | 0.00% | 0.22% |
| JPMORGAN CHASE & CO | 02/11/2026 | 49.82 K | $516.64 K | -50.02% | 0.22% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 45.65 K | $473.37 K | 0.00% | 0.20% |
| UBS GROUP AG | 01/29/2026 | 38.16 K | $395.71 M | 89.65% | 0.17% |
| DAKOTA WEALTH MANAGEMENT | 01/13/2026 | 36.40 K | $377.47 K | 0.00% | 0.16% |
| HRT FINANCIAL LP | 02/12/2026 | 28.28 K | $293.00 K | 2.89% | 0.12% |
| MORGAN STANLEY | 02/13/2026 | 121 | $1.26 K | 278.13% | 0.00% |
| SANDIA INVESTMENT MANAGEMENT LP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Drugs Made In America Acquisition Corp. institutional Ownership - FAQ's
During the previous two years, 29 institutional investors and hedge funds held shares of Drugs Made In America Acquisition Corp.. The most heavily invested institutionals were:
First Trust Capital Management L.P.: 2.24 M
GLAZER CAPITAL, LLC: 1.82 M
Westchester Capital Management, LLC: 1.67 M
Hudson Bay Capital Management LP: 1.55 M
MIZUHO SECURITIES USA LLC: 1.43 M
WOLVERINE ASSET MANAGEMENT LLC: 1.31 M
16.78% of Drugs Made In America Acquisition Corp. stock is owned by institutional investors.
Institutional investors have bought a total of 14.60 M shares in the last 24 months. This purchase volume represents approximately $152.33 M in transactions.